News Keytruda approved for bladder cancer in Europe, first to pro... Merck Sharp & Dohme’s Keytruda has been approved in Europe for metastatic urothelial carcinoma, a move which helps it catch up with its immunotherapy rivals.
News FDA probes blood cancer immunotherapy safety Regulator reviewing combination therapy safety after issue with Keytruda
Views & Analysis Evolving immunotherapy strategies in NSCLC Status of immunotherapies in non-small cell lung cancer (NSCLC).
News Clovis and BMS combine cancer drugs in late-stage trials Clovis and BMS research small molecule and antibody combination.
News Roche raises outlook for 2017 following strong launches The launch of three new products with blockbuster potential helped increase Roche’s revenues 5% in
News Europe recommends Tecentriq in bladder cancer, but efficacy ... The European Union’s CHMP committee recommended 11 medicines on Friday, including five orphan drugs.
News Isomorphic adds MSD to partner roster, and other deals It's been a busy dealmaking week, with Isomorphic Labs, fresh from a $5 billion financing, adding MSD to its list of research alliances.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.